Implementation and Evaluation of a Stochastic Control Strategy for Individualizing Teicoplanin Dosage Regimen

By Tod Michel   Alet Patrice   Lortholary Olivier   Petitjean Olivier  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 695-712

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic Strategies for Individualizing Therapy of Acute MyeloidLeukemia (AML)

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 159-170

Bentham Science Publishers

Access to resources Recommend Favorite

Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 176-186

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk

By  

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-11 ,pp. : 5676-5686

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy

By Krens Stefanie D   McLeod Howard L   Hertz Daniel L  

Pharmacogenomics, Vol. 14, Iss. 5, 2013-04 ,pp. : 555-574

Future Medicine

Access to resources Recommend Favorite